P3 Research is running a new hepatitis B clinical trial in Tauranga, the Hawke's Bay, Wellington and Waikanae for people already taking antiviral medications. Volunteers are being sought for this trial.
P3 Research is one of many pharmaceutical companies working on a cure for hepatitis B. The process includes clinical trials, which give patients a chance to get involved with developing a cure.
New Zealand is supporting the World Health Organisation's goal of eliminating global hepatitis by 2030, and these clinical trials are helping us work towards that goal.
